Please login to the form below

Not currently logged in
Email:
Password:

HTA guidance from NICE, the SMC and the AWMSG

Here we present a feed of upcoming health technology assessment (HTA) decisions, covering appraisals by the National Institute of Health and Care Excellence (NICE), the Scottish Medicines Consortium (SMC) and the All Wales Medicines Strategy Group (AWMSG).

Provided by Guidelines, it also features: NICE clinical guidelines, NICE quality standards, NICE evidence updates, NICE evidence summaries, independent professional body guidelines and (Scottish Intercollegiate Guidelines Network (SIGN) guidance.

Combined hormonal contraception—update (Faculty of Sexual & Reproductive Healthcare)

September 2018: Independent professional body guideline

Asthma (update)

September 2018: NICE Quality Standard

Depression in adults (update)

September 2018: NICE Quality Standard

Eating disorders

September 2018: NICE Quality Standard

Ovarian cancer (refresh)

September 2018: SIGN guidance

Renal replacement therapy

October 2018: NICE Clinical Guideline

Decision making and mental capacity

October 2018: NICE Social Care Guidance

Foetal alcohol spectrum disorder (update)

October 2018: SIGN guidance

Abdominal aortic aneurysm: diagnosis and management

November 2018: NICE Clinical Guideline

Contraceptive choices for women who are obese/overweight

November 2018: Independent professional body guideline

Visit the Guidelines website

NICE turns down bluebird bio’s gene therapy Zynteglo

NICE turns down bluebird bio’s gene therapy Zynteglo 11 Feb 2021
NICE did add, however, that these trials suggest that eventually certain TDT patients treated with Zynteglo may no longer require blood transfusion or may require them less often. ... NICE’s draft guidance of Zynteglo is open for consultation until 4

Gilead’s Jyseleca is given a NICE recommendation for rheumatoid arthritis

Gilead’s Jyseleca is given a NICE recommendation for rheumatoid arthritis 22 Jan 2021
Care Excellence (NICE). ... This is a landmark decision from NICE and represents a pivotal moment for the treatment of RA,” said James Galloway, consultant rheumatologist at King’s College London Hospital.

Pierre Fabre’s Braftovi scores NICE backing for BRAF+ colorectal cancer

Pierre Fabre’s Braftovi scores NICE backing for BRAF+ colorectal cancer 20 Nov 2020
Securing NHS reimbursement is the culmination of collaborative discussions that we have been having with NICE and NHS England since the end of last year,” said Laura McMullin, general manager UK ... We worked closely with clinicians to submit evidence

NICE launches consultation on its methods of drug evaluation

NICE launches consultation on its methods of drug evaluation 9 Nov 2020
In addition, new cancer treatments can be approved via NICE’s Cancer Drugs Fund (CDF) which was introduced in 2016. ... NICE said there is also a ‘case for change’ regarding how it values costs and health effects for health technologies.

Novartis’ MS therapy Mayzent approved by NICE

Novartis’ MS therapy Mayzent approved by NICE 16 Oct 2020
Mayzent (siponimod), a sphinogosine 1-phosphate receptor modulator, is the first oral disease-modifying treatment recommended by both NICE and the Scottish Medicines Consortium (SMC) for SPMS with active disease. ... According to NICE, around 11, 000

More news from PMLiVE on NICE, the SMC and the AWMSG

MGP’s Guidelines brand is trusted by over 58,000 healthcare professionals for concise clinical summaries of major primary and shared care guidelines in the UK. Through Guidelines, Guidelines for Nurses and Guidelines in Practice, MGP connect pharmaceutical and medical device companies to an engaged audience of GPs, GP commissioners and payers, nurses and allied healthcare professionals.

To discuss how we can support your guidance or implementation needs please contact marketing@mgp.co.uk

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Infographics